Live Breaking News & Updates on Emerging Innovations

Stay updated with breaking news from Emerging innovations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference


NEW YORK, March 10, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer will present a corporate update at the
Inaugural Emerging Growth Virtual Conference, held by M Vest LLC and Maxim Group LLC. The conference will take place on March 17th - 19th from 9:00 AM to 5:00 PM EDT.
During this virtual conference, the Company will present along with other important voices in the healthcare sector. The conference will feature roundtable discussions, issuer presentations, fireside chats, and live Q&A with company CEOs moderated by Maxim research analysts. To attend and access conference content, sign up to become an M-Vest member for more updates HERE. ....

New York , United States , Beth Amorosi , Shaun Oneil , Katie Gallagher , Lishan Aklog , Mike Havrilla , Lucid Diagnostics Inc , Gi Health Esoguard , Exchange Commission , Maxim Group , M Vest , Pavmed Inc , Globe Newswire Pavmed Inc , Chief Executive Officer , Inaugural Emerging Growth Virtual Conference , New York City , Municipal Securities Rulemaking Board , Esophageal Cell Collection Device , Esophageal Ablation Device , Minimally Invasive Interventions , Minimally Invasive Device , Carpal Tunnel Syndrome , Infusion Therapy , Implantable Intraosseus Vascular Access Device , Emerging Innovations ,

PAVmed Announces Closing of its Public Offering of Common Stock


PAVmed Announces Closing of its Public Offering of Common Stock
02/25/2021 | 01:38pm EDT
Send by mail :
Message :
NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced underwritten public offering (the “Offering”) of approximately 9.8 million shares of its common stock for gross proceeds of approximately $45 million, before deducting underwriting discounts and commissions and other offering expenses payable by PAVmed.
Cantor Fitzgerald & Co. acted as sole bookrunner for the Offering. Lake Street Capital Markets LLC and Maxim Group LLC acted as financial advisors to the Company. ....

New York , United States , Shaun Oneil , Katie Gallagher , Mike Havrilla , Capital Markets , Cantor Fitzgerald Co , Gi Health Esoguard , Exchange Commission , Maxim Group , Pavmed Inc , Globe Newswire Pavmed Inc , Accurate Infusion Platform Technology , Lake Street Capital Markets , Cantor Fitzgerald , Esophageal Cell Collection Device , Esophageal Ablation Device , Minimally Invasive Interventions , Minimally Invasive Device , Carpal Tunnel Syndrome , Infusion Therapy , Implantable Intraosseus Vascular Access Device , Highly Accurate Infusion Platform Technology , Emerging Innovations , Seriesw Warrants , Seriesz Warrants ,

PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST


PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
Conference call and live webcast was previously scheduled for 4:30 PM EST
Lucid Diagnostics strategic advisor and medical diagnostics pioneer Stanley Lapidus to join call
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company has moved the time of its business update conference call on Monday, February 22, 2021 to 8:30 AM EST to accommodate the schedule of PAVmed subsidiary Lucid Diagnostics Inc’s (“Lucid”) Strategic Advisor, medical diagnostics pioneer Stanley Lapidus.
Mr. Lapidus will join PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., and President and Chief Financial Officer Dennis McGrath on the call. Mr. McGrath will provide a financial update on the Company. Dr. Aklog will pr ....

United States , Dennis Mcgrath , Stanley Lapidus , Shaun Oneil , Katie Gallagher , Lishan Aklog , Mike Havrilla , Biosystems Inc , Board Of Directors Binx Health Inc , Lapiddx Research , Fractyl Laboratories Inc , Cytyc Inc , Lucid Diagnostics Inc , Glympse Bio Inc , Pathai Inc , Massachusetts Institute Of Technology , Lucid Diagnostics Inc Strategic Advisor , Gi Health Esoguard , Exchange Commission , Pavmed Inc , Strategic Advisor , Chief Executive Officer Lishan Aklog , Chief Financial Officer Dennis Mcgrath , Exact Sciences , Binx Health Inc , Fractyl Laboratories ,